| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
J. Biol. Chem., Vol. 281, Issue 19, 13784-13793, May 12, 2006
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Institute for Medical Microbiology, Immunology, and Hygiene, Center for Molecular Medicine-Cologne, University of Cologne, 50935 Köln, Germany
Two genes encoding neutral sphingomyelinases-1 and -2 (sphingomyelin phosphodiesterases-2 and -3) have been recently identified that hydrolyze sphingomyelin to phosphorylcholine and ceramide. Data bank searches using a peptide sequence derived from a previously purified bovine neutral sphingomyelinase (nSMase) allowed us to identify a cDNA encoding a novel human sphingomyelinase, nSMase3, that shows only a little homology to nSMase1 and -2. nSMase3 was biochemically characterized by overexpression in a yeast strain, JK9-3d
Isc1p, lacking endogenous SMase activity. Similar to nSMase2, nSMase3 is Mg2+-dependent and shows optimal activity at pH 7, which is enhanced in the presence of phosphatidylserine and inhibited by scyphostatin. nSMase3 is ubiquitously expressed as a 4.6-kb mRNA species. nSMase3 lacks an N-terminal signal peptide, yet contains a 23-amino-acid transmembrane domain close to the C terminus, which is indicative for the family of C-tail-anchored integral membrane proteins. Cellular localization studies with hemagglutinin-tagged nSMase3 demonstrated colocalization with markers of the endoplasmic reticulum as well as with Golgi markers. Tumor necrosis factor stimulates rapid activation of nSMase3 in MCF7 cells with peak activity at 1.5 min, which was impaired by expression of dominant negative FAN.
Received for publication, October 18, 2005 , and in revised form, March 1, 2006.
* This work was supported by Deutsche Forschung Gemeinschaft (DFG KR 810/12-4). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 Both authors contributed equally to this work.
2 To whom correspondence should be addressed: Institute for Medical Microbiology, Immunology, and Hygiene, University of Cologne, Goldenfelsstr. 19-21, 50935 Köln, Germany. Tel.: 49-221-478-32000; Fax: 49-221-478-32002; E-mail: M.Kroenke{at}uni-koeln.de.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  C. A. Corcoran, Q. He, S. Ponnusamy, B. Ogretmen, Y. Huang, and M. S. Sheikh Neutral Sphingomyelinase-3 Is a DNA Damage and Nongenotoxic Stress-Regulated Gene That Is Deregulated in Human Malignancies Mol. Cancer Res., May 1, 2008; 6(5): 795 - 807. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. J. Kim, R. A. Okimoto, L. E. Purton, M. Goodwin, S. M. Haserlat, F. Dayyani, D. A. Sweetser, A. I. McClatchey, O. A. Bernard, A. T. Look, et al. Mutations in the neutral sphingomyelinase gene SMPD3 implicate the ceramide pathway in human leukemias Blood, May 1, 2008; 111(9): 4716 - 4722. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Coll, A. Morales, J. C. Fernandez-Checa, and C. Garcia-Ruiz Neutral sphingomyelinase-induced ceramide triggers germinal vesicle breakdown and oxidant-dependent apoptosis in Xenopus laevis oocytes J. Lipid Res., September 1, 2007; 48(9): 1924 - 1935. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Tani and Y. A. Hannun Neutral Sphingomyelinase 2 Is Palmitoylated on Multiple Cysteine Residues: ROLE OF PALMITOYLATION IN SUBCELLULAR LOCALIZATION J. Biol. Chem., March 30, 2007; 282(13): 10047 - 10056. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |
